EOLS Competitors & Alternatives

Compare Evolus Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EOLS

Main Stock
$6.52
Tradestie Score
56
Market Cap
$397.82M
Revenue Growth
0.1%
Analyst Upside
+124.9%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.75
$1.02B - 61 Compare
ANAB AnaptysBio, Inc. Common Stock
$69.81
$894.30M - 64 Compare
EYPT EyePoint Pharmaceuticals, Inc. Common Stock
$14.28
$890.20M - 56 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.06
$711.32M - 53 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 55 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.34
$543.32M - 58 Compare
SLDB Solid Biosciences Inc. Common Stock
$9.72
$457.09M - 60 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.21
$237.15M 7.2 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$21.79
$212.23M - 55 Compare
MGNX MacroGenics, Inc.
$4.50
$107.45M - 59 Compare

Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry